New drug policy welcome move: Pharma companies

The new drug price control policy that has recently been notified is likely to be a boon for consumers as it will put an end to the 'arbitrary' pricing regime and bring down medicine prices, say......

Indian pharmaceutical M&As see unhealthy decline

The value of mergers and acquisitionsby Indian pharmaceutical and healthcare companies has declined sharply in the second half (H2) of 2007-08, suggesting that heady days of large buyouts are......

Pharmaceutical firms opt for inlicensing

Ranbaxy Laboratories, Dr Reddy's Laboratories, Nicholas Piramal and other pharmaceutical companies are betting on inlicensing or strategic marketing tie-ups to help grow local sales after India......

Indian pharma prefers non-litigation route in US

The Indian pharmaceutical companies are involved in patent litigations of a mere 40 drugs, out of the 135 known patent litigation drugs in the US. This is despite the claims by major Indian......